← All trials
NCT05716607
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2023
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2026
- First posted
- Feb 8, 2023
- Last posted
- Apr 18, 2023
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Vastra Gotaland RegionLead sponsor
- Pilloxa ABCollaborator
- University of GothenburgCollaborator
- University of GothenburgOverall official - principal investigator
- The Gothenburg Society of MedicineCollaborator
- Vastra Gotaland RegionReponsible party - principal investigator
- Vastra Gotaland RegionSponsor investigator
- University of GothenburgOfficial
- The Swedish Society of MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.